# Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fasting

> **NCT00836472** · PHASE1 · COMPLETED · sponsor: **Teva Pharmaceuticals USA** · enrollment: 60 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Glyburide/Metformin 5 mg/500 mg Tablets
- **DRUG:** Glucovance® 5 mg/500 mg Tablets

## Key facts

- **NCT ID:** NCT00836472
- **Lead sponsor:** Teva Pharmaceuticals USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2003-04
- **Final completion:** 2003-04
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00836472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00836472, "Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fasting". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00836472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*